|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/113 | (2010.01) |
| (11) | Number of the document | 3356529 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16852695.2 |
| Date of filing the European patent application | 2016-09-30 | |
| (97) | Date of publication of the European application | 2018-08-08 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-25 |
| (46) | Date of publication of the claims translation | 2021-12-27 |
| (86) | Number | PCT/US2016/054729 |
| Date | 2016-09-30 |
| (87) | Number | WO 2017/059223 |
| Date | 2017-04-06 |
| (30) | Number | Date | Country code |
| 201562235816 P | 2015-10-01 | US | |
| 201662346304 P | 2016-06-06 | US | |
| 201662383221 P | 2016-09-02 | US |
| (72) |
MELQUIST, Stacey , US
KANNER, Steven , US
ROZEMA, David, B. , US
LEWIS, David, L. , US
ALMEIDA, Lauren, J. , US
WAKEFIELD, Darren, H , US
TRUBETSKOY, Vladimir, S. , US
PEI, Tao , US
LI, Zhen , US
ALMEIDA, Aaron , US
|
| (73) |
Arrowhead Pharmaceuticals, Inc. ,
177 E. Colorado Boulevard, Suite 700, Pasadena, CA 91105,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Kompozicijos ir būdai, skirti LPA genų raiškos slopinimui |
| COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION OF LPA |
| Payment date | Validity (years) | Amount | |
| 2025-08-20 | 10 | 231.00 EUR |
| 2026-09-30 |